nuMoM2b Heart Health Study
nuMoM2b-HHS
Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes as Predictors of Increased Risk Factors for Cardiovascular Disease
2 other identifiers
observational
4,509
1 country
15
Brief Summary
This study is looking at the relationship between experiences during pregnancy and cardiovascular health 2 to 3½ years later. The investigators are recruiting women from the approximately 10,000 women who were enrolled and followed over the course of their first pregnancy in another study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedFirst Posted
Study publicly available on registry
September 4, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFebruary 16, 2022
January 1, 2022
3.2 years
August 28, 2014
January 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypertension, defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg
Will exclude participants with chronic hypertension or pregestational diabetes during or just prior to the index pregnancy.
Blood pressures taken at study clinic visit between 2 and 3.5 years postpartum
Secondary Outcomes (9)
Systolic blood pressure in mm Hg
Blood pressures taken at study clinic visit between 2 and 3.5 years postpartum
Diastolic blood pressures in mm Hg
Blood pressures taken at study clinic visit between 2 and 3.5 years postpartum
HDL cholesterol in mg/dL from blood sample following overnight fast of at least 8 hours
Blood sample taken at study clinic visit between 2 and 3.5 years postpartum
LDL cholesterol in mg/dL from blood sample following overnight fast of at least 8 hours
Blood sample taken at study clinic visit between 2 and 3.5 years postpartum
Triglycerides in mg/dL from blood sample following overnight fast of at least 8 hours
Blood sample taken at study clinic visit between 2 and 3.5 years postpartum
- +4 more secondary outcomes
Other Outcomes (1)
N-terminal of the Prohormone Brain Natriuretic peptide (NT-proBNP) in pg/mL from blood sample following overnight fast of at least 8 hours
Blood sample taken at study clinic visit between 2 and 3.5 years postpartum
Study Arms (1)
Women who participated in nuMoM2b
Eligibility Criteria
Eligible women are recruited from the cohort enrolled to nuMoM2b. For nuMom2b a convenience sample was recruited through 8 primary clinical sites that NIH selected because they could each demonstrate access to more than 4,500 deliveries per year. As a group, sites were geographically dispersed and ethically diverse. All nulliparous women aged 13 years or greater with a singleton pregnancy less than 13 weeks 6 days gestation who presented at recruitment clinics or practices and planned to deliver at a study hospital were potentially eligible for participation. A clinical or research ultrasound, performed by a study certified sonographer, confirmed viability of a singleton gestation with no obvious malformations and estimated gestational age less than or equal to 13 weeks 6 days before the woman was allowed enrollment. The first visit was scheduled and completed within a window of 6 weeks 0 days and 13 weeks 6 days estimated gestational age.
You may qualify if:
- Interval Contact:
- Agreed to contact for future studies during nuMoM2b and not subsequently withdrawn from the cohort.
- Have pregnancy outcome data from the nuMoM2b study.
- At least 18 years of age (to begin interval contact attempts once nuMoM2b participant reaches age 18).
- Provision of verbal consent for telephone interview or acknowledgement of consent with completion of the web-based self-administered questionnaire.
- In-clinic Visit:
- Consented for participation in interval contacts and not subsequently withdrawn
- Between 2 and 3.5 years after the nuMoM2b pregnancy ended
- Self-report at least 6 months postpartum from any subsequent pregnancy
- Self-report not currently pregnant
- Able to provide informed consent
- Provision of written, signed, informed consent for the 2 to 3.5 year in-clinic assessment
- Not currently pregnant by urine pregnancy test administered in the clinic following consent
- In-home Sleep Breathing Assessment after the In-Clinic Visit:
- Participation in the in-clinic visit
- +6 more criteria
You may not qualify if:
- Inability or refusal to provide informed consent for the study component.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Fountain Valley Regional Hospital and Medical Center- UCI MFM private practice
Fountain Valley, California, 92708, United States
Long Beach Memorial Medical Center, Women's and Children's Hospital - Women's Perinatal Group, OB Clinic
Long Beach, California, 90801, United States
University of California, Irvine, Medical Center - Prenatal care clinics and private practice
Orange, California, 92868, United States
Christiana Care Health Systems
Newark, Delaware, 19718, United States
Northwestern University
Chicago, Illinois, 60611, United States
Indiana University School of Medicine OB/GYN
Indianapolis, Indiana, 46202, United States
Columbia University Medical Center- Department of OB/GYN Division of Maternal Fetal Medicine
New York, New York, 10032, United States
Case Western Reserve University, MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
McKay Dee Hospital
Ogden, Utah, 84403, United States
Utah Valley Regional Medical Center
Provo, Utah, 84604, United States
University of Utah
Salt Lake City, Utah, 84106, United States
Intermountain Medical Center
Salt Lake City, Utah, 84107, United States
LDS Hospital
Salt Lake City, Utah, 84143, United States
Related Publications (9)
Haas DM, Ehrenthal DB, Koch MA, Catov JM, Barnes SE, Facco F, Parker CB, Mercer BM, Bairey-Merz CN, Silver RM, Wapner RJ, Simhan HN, Hoffman MK, Grobman WA, Greenland P, Wing DA, Saade GR, Parry S, Zee PC, Reddy UM, Pemberton VL, Burwen DR; National Heart, Lung, and Blood Institute nuMoM2b Heart Health Study Network. Pregnancy as a Window to Future Cardiovascular Health: Design and Implementation of the nuMoM2b Heart Health Study. Am J Epidemiol. 2016 Mar 15;183(6):519-30. doi: 10.1093/aje/kwv309. Epub 2016 Jan 28.
PMID: 26825925BACKGROUNDCatov JM, Parker CB, Gibbs BB, Bann CM, Carper B, Silver RM, Simhan HN, Parry S, Chung JH, Haas DM, Wapner RJ, Saade GR, Mercer BM, Bairey-Merz CN, Greenland P, Ehrenthal DB, Barnes SE, Shanks AL, Reddy UM, Grobman WA; NICHD NuMoM2b and NHLBI NuMoM2b Heart Health Study Network. Patterns of leisure-time physical activity across pregnancy and adverse pregnancy outcomes. Int J Behav Nutr Phys Act. 2018 Jul 11;15(1):68. doi: 10.1186/s12966-018-0701-5.
PMID: 29996930BACKGROUNDFacco FL, Parker CB, Hunter S, Reid KJ, Zee PC, Silver RM, Haas DM, Chung JH, Pien GW, Nhan-Chang CL, Simhan HN, Parry S, Wapner RJ, Saade GR, Mercer BM, Torres C, Knight J, Reddy UM, Grobman WA; NICHD NuMoM2b and NHLBI NuMoM2b Heart Health Study Networks. Association of Adverse Pregnancy Outcomes With Self-Reported Measures of Sleep Duration and Timing in Women Who Are Nulliparous. J Clin Sleep Med. 2018 Dec 15;14(12):2047-2056. doi: 10.5664/jcsm.7534.
PMID: 30518449BACKGROUNDHaas DM, Yang Z, Parker CB, Chung J, Parry S, Grobman WA, Mercer BM, Simhan HN, Silver RM, Wapner RJ, Saade GR, Greenland P, Merz NB, Reddy UM, Pemberton VL; nuMoM2b study and the nuMoM2b Heart Health Study. Factors associated with duration of breastfeeding in women giving birth for the first time. BMC Pregnancy Childbirth. 2022 Sep 22;22(1):722. doi: 10.1186/s12884-022-05038-7.
PMID: 36138368DERIVEDFacco FL, Redline S, Hunter SM, Zee PC, Grobman WA, Silver RM, Louis JM, Pien GW, Mercer B, Chung JH, Bairey Merz CN, Haas DM, Nhan-Chang CL, Simhan HN, Schubert FP, Parry S, Reddy U, Saade GR, Hoffman MK, Levine LD, Wapner RJ, Catov JM, Parker CB. Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic Health. Am J Respir Crit Care Med. 2022 May 15;205(10):1202-1213. doi: 10.1164/rccm.202104-0971OC.
PMID: 35144521DERIVEDHawkins M, Parker CB, Redline S, Larkin JC, Zee PP, Grobman WA, Silver RM, Louis JM, Pien GW, Basner RC, Chung JH, Haas DM, Nhan-Chang CL, Simhan HN, Blue NR, Parry S, Reddy U, Facco F; NICHD NuMoM2b and NHLBI NuMoM2b Heart Health Study Networks. Objectively assessed sleep-disordered breathing during pregnancy and infant birthweight. Sleep Med. 2021 May;81:312-318. doi: 10.1016/j.sleep.2021.02.043. Epub 2021 Feb 27.
PMID: 33756281DERIVEDCatov JM, McNeil RB, Marsh DJ, Mercer BM, Bairey Merz CN, Parker CB, Pemberton VL, Saade GR, Chen YI, Chung JH, Ehrenthal DB, Grobman WA, Haas DM, Parry S, Polito L, Reddy UM, Silver RM, Simhan HN, Wapner RJ, Kominiarek M, Kreutz R, Levine LD, Greenland P; NHLBI nuMoM2b Heart Health Study. Early Pregnancy Atherogenic Profile in a First Pregnancy and Hypertension Risk 2 to 7 Years After Delivery. J Am Heart Assoc. 2021 Feb;10(5):e017216. doi: 10.1161/JAHA.120.017216. Epub 2021 Feb 23.
PMID: 33619977DERIVEDHaas DM, Parker CB, Marsh DJ, Grobman WA, Ehrenthal DB, Greenland P, Bairey Merz CN, Pemberton VL, Silver RM, Barnes S, McNeil RB, Cleary K, Reddy UM, Chung JH, Parry S, Theilen LH, Blumenthal EA, Levine LD, Mercer BM, Simhan H, Polito L, Wapner RJ, Catov J, Chen I, Saade GR; NHLBI nuMoM2b Heart Health Study. Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum. J Am Heart Assoc. 2019 Oct;8(19):e013092. doi: 10.1161/JAHA.119.013092. Epub 2019 Sep 30.
PMID: 31564189DERIVEDMonk C, Webster RS, McNeil RB, Parker CB, Catov JM, Greenland P, Bairey Merz CN, Silver RM, Simhan HN, Ehrenthal DB, Chung JH, Haas DM, Mercer BM, Parry S, Polito L, Reddy UM, Saade GR, Grobman WA; NICHD nuMoM2b and NHLBI nuMoM2b Heart Health Study Networks. Associations of perceived prenatal stress and adverse pregnancy outcomes with perceived stress years after delivery. Arch Womens Ment Health. 2020 Jun;23(3):361-369. doi: 10.1007/s00737-019-00970-8. Epub 2019 Jun 29.
PMID: 31256258DERIVED
Biospecimen
Blood Samples: A research or clinical staff member collects a fasting blood draw from the participant: 2 SST (tiger top) 10 mL tubes for serum; 2 EDTA (purple top) 10 mL tubes for plasma, and 1 (light blue top) 2.7 mL tube for citrated plasma. Less than 3 tablespoons of blood are collected. A 0.5 mL aliquot of whole blood from the EDTA tube is reserved. The rest of the blood is processed and as many 0.5 mL aliquots of serum, EDTA plasma, and citrated plasma as possible are collected. In addition, a 1.5 mL aliquot of buffy coat is collected from one of the EDTA tubes. Urine Sample: A research or clinical staff member collects about 20 mL of clean catch urine from the participant and 2 urine aliquots (1.8 mL each).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
George Saade, M.D.
The University of Texas Medical Branch, Galveston
- PRINCIPAL INVESTIGATOR
Brian M. Mercer, MD
Case Western Reserve University
- PRINCIPAL INVESTIGATOR
Ronald Wapner, MD
Columbia University
- PRINCIPAL INVESTIGATOR
David M. Haas, M.D., M.S.,
Indiana University
- PRINCIPAL INVESTIGATOR
Hyagriv N. Simhan, MD, MSCR
Magee Womens Hospital - University of Pittsburgh
- PRINCIPAL INVESTIGATOR
William Grobman, M.D., M.B.A.
Northwestern University
- PRINCIPAL INVESTIGATOR
Judith Chung, M.D.
University CA Irvine
- PRINCIPAL INVESTIGATOR
Samuel Parry, M.D.
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Robert M. Silver, M.D.
University of Utah
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Statistician
Study Record Dates
First Submitted
August 28, 2014
First Posted
September 4, 2014
Study Start
September 1, 2014
Primary Completion
October 30, 2017
Study Completion
October 30, 2020
Last Updated
February 16, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
De-identified data will be made available through an NIH data repository.